Vaxart COVID-19 vaccine
From WikiProjectMed
Jump to navigation
Jump to search
Vaccine candidate against COVID-19
Vaccine description | |
---|---|
Target | SARS-CoV-2 |
Vaccine type | Viral vector |
Clinical data | |
Other names | VXA-CoV2-1, VXA-CoV2-1.1-S |
Routes of administration | Oral |
Vaxart COVID-19 vaccine is a COVID-19 vaccine candidate developed by Vaxart.[1][2][3]
References
- ^ Clinical trial number NCT04563702 for "Safety and Immunogenicity Trial of an Oral SARS-CoV-2 Vaccine (VXA-CoV2-1) for Prevention of COVID-19 in Healthy Adults" at ClinicalTrials.gov
- ^ Clinical trial number NCT05067933 for "Ph 1b: Safety & Immunogenicity of Ad5 Based Oral Norovirus Vaccine (VXA-NVV-104)" at ClinicalTrials.gov
- ^ Clinical trial number NCT05067933 for "A Ph 2 Trial With an Oral Tableted COVID-19 Vaccine" at ClinicalTrials.gov
Scholia has a profile for Vaxart COVID-19 vaccine (Q110269782).
Development | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Classes | |||||||||||
Administration | |||||||||||
Vaccines |
| ||||||||||
Inventors/ researchers | |||||||||||
Controversy | |||||||||||
Related | |||||||||||
|
Retrieved from "https://mdwiki.org/wiki/Vaxart_COVID-19_vaccine"
Categories:
- Articles with short description
- Short description matches Wikidata
- Use dmy dates from December 2021
- Chemical articles without CAS registry number
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs missing an ATC code
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- Drugs that are a vaccine
- American COVID-19 vaccines
- Clinical trials related to COVID-19
- Viral vector vaccines